Factors Influencing the Mortality of Patients With Subarachnoid Haemorrhage
NCT ID: NCT06490640
Last Updated: 2024-07-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
117 participants
OBSERVATIONAL
2024-03-01
2024-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Machine Learning Predictive Models for Sepsis Risk in ICU Patients With Intracerebral Hemorrhage
NCT06326385
Study of Prognostic Factors in Patients Admitted to ICU for Stroke
NCT04434287
Spleen Volume Change Predicts 45-Day Mortality in Neurocritical Care: A Prospective Cohort Study
NCT07132996
Can Shock Indices Be Prognostic Indicators in Sepsis/Septic Shock?
NCT06415006
Predictors of Mortality in Traumatic Brain Injury Patients in Intensive Care Unit
NCT06183749
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Spontaneous subarachnoid haemorrhage survival cohort
Demographic and clinical data derived and analyzed included age, sex, smoking history, comorbidities. Presenting signs and symptoms, diagnoses responsible for spontaneous SAH (aneurysm, arterial malformation, etc.), site of aneurysm, risk factors, location of the aneurysm, risk factors, blood pressure during ICU admission, and scores from grading systems indicating clinical and radiological severity of the disease were recorded. Procedures for spontaneous SAH, complications during ICU follow-up (vasospasm, meningitis, electrolyte disturbances, rebleeding, DCI, VIP, sepsis/septic shock) and treatments, duration of ICU stay and mechanical ventilation, ICU outcome (survival or mortality), causes of mortality and brain death status were recorded.
Spontaneous subarachnoid haemorrhage survival cohort
consists of surviving patients
Spontaneous subarachnoid haemorrhage mortality cohort
Demographic and clinical data derived and analyzed included age, sex, smoking history, comorbidities. Presenting signs and symptoms, diagnoses responsible for spontaneous SAH (aneurysm, arterial malformation, etc.), site of aneurysm, risk factors, location of the aneurysm, risk factors, blood pressure during ICU admission, and scores from grading systems indicating clinical and radiological severity of the disease were recorded. Procedures for spontaneous SAH, complications during ICU follow-up (vasospasm, meningitis, electrolyte disturbances, rebleeding, DCI, VIP, sepsis/septic shock) and treatments, duration of ICU stay and mechanical ventilation, ICU outcome (survival or mortality), causes of mortality and brain death status were recorded.
Spontaneous subarachnoid haemorrhage mortality cohort
consists of deceased patients
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Spontaneous subarachnoid haemorrhage survival cohort
consists of surviving patients
Spontaneous subarachnoid haemorrhage mortality cohort
consists of deceased patients
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with a final outcome (survival or mortality) in our centre
Exclusion Criteria
* History of significant head trauma in the previous two weeks (any abnormality on brain CT requiring hospitalisation for more than 24 hours)
* Pregnancy
* Length of intensive care unit stay ≤24 hours
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Melike Cengiz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Melike Cengiz
MD,Professor Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ulku Arslan Yildiz, MD
Role: PRINCIPAL_INVESTIGATOR
Akdeniz University School of Medicine, Department of Anesthesiology and Intensive Care, Turkey
Murat Yilmaz, Professor
Role: PRINCIPAL_INVESTIGATOR
Akdeniz University School of Medicine, Department of Anesthesiology and Intensive Care, Turkey
Onur Cetinkaya, MD
Role: PRINCIPAL_INVESTIGATOR
Akdeniz University School of Medicine, Department of Anesthesiology and Intensive Care, Turkey
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Akdeniz University School of Medicine, Department of Anesthesiology and Intensive Care, Turkey
Antalya, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Akdeniz U.
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.